Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Sunburn 1 Stress, Psychological 1 Stress Disorders, Post-Traumatic 1 Smoking Cessation 1 Prostatic Hyperplasia 1 Motor Activity 1 Melanoma 1 Head and Neck Neoplasms 1 Depression 1 Anxiety Disorders 1 Alzheimer Disease 1 Acquired Immunodeficiency Syndrome 1

Interventions

Cisplatin 253 Radiotherapy 176 Cetuximab 145 pembrolizumab 120 Docetaxel 97 Fluorouracil 92 Carboplatin 80 Paclitaxel 77 Radiotherapy, Intensity-Modulated 69 Nivolumab 37 Radiation 30 Drug Therapy 30 Erlotinib Hydrochloride 26 Gemcitabine 25 Cyclophosphamide 22 Gefitinib 21 Surveys and Questionnaires 20 Standard of Care 20 Surgical Procedures, Operative 19 Pemetrexed 19 durvalumab 18 Magnetic Resonance Spectroscopy 17 Capecitabine 17 Radiosurgery 16 Celecoxib 16 atezolizumab 15 Filgrastim 15 Amifostine 15 130-nm albumin-bound paclitaxel 15 fludarabine 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × Amyloid × Clear all

NCT05997329 2025-09-08

NUTREAT

University of Oslo

Phase NA Active not recruiting

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡